Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
Desheva, J.A., Lu, X.H., Rekstin, A.R., Rudenko, L.G., Swayne, D.E., Cox, N.J., Katz, J.M., Klimov, A.I.
Published in Vaccine (17.11.2006)
Published in Vaccine (17.11.2006)
Get full text
Journal Article
Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines
Desheva, J.A, Rudenko, L.G, Alexandrova, G.I, Lu, X, Rekstin, A.R, Katz, J.M, Cox, N.J, Klimov, A.I
Published in International Congress series (01.06.2004)
Published in International Congress series (01.06.2004)
Get full text
Journal Article
Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age
Klimov, A.I., Kiseleva, I.V., Desheva, J.A., Alexandrova, G.I., Cox, N.J., Rudenko, L.G.
Published in International Congress series (01.10.2001)
Published in International Congress series (01.10.2001)
Get full text
Journal Article
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
Desheva, J.A, Lu, X.H, Rekstin, A.R, Rudenko, L.G, Swayne, D.E, Cox, N.J, Katz, J.M, Klimov, A.I
Published in Vaccine (2006)
Get more information
Published in Vaccine (2006)
Publication